Mass spectrometry platform could shrink cancer drug discovery cycle to four hours

Medical Xpress

Mass spectrometry platform could shrink cancer drug discovery cycle to four hours

Researchers at the Purdue Institute for Cancer Research (PICR) have developed a next-generation technology platform designed to accelerate one of the slowest and most challenging stages of cancer drug discovery: identifying promising compounds that could eventually become new therapies. ...

전문 보기

이 뉴스, 독자들은 어떻게 느꼈나요?

첫 반응을 남겨보세요

로그인하면 감정 반응에 참여할 수 있어요.

Mass spectrometry platform could shrink cancer drug discovery cycle to four hours

이 뉴스, 독자들은 어떻게 느꼈나요?

관련 뉴스

'science' 카테고리 뉴스

Eight ways to sleep well in hot weather

New nanotube membranes reveal unusually fast lithium-ion transport

Later menarche may signal childhood factors linked to adult health risks

Medical Xpress의 다른 기사

First new US sunscreen ingredient since 1999 approved by FDA. A skin scientist explains how bemotrizinol works

How people use music shapes their emotional experiences, new study finds

Nordic walking significantly reduces depression symptoms in as little as five weeks, trial finds